US equities
|
MU
$942.21
▼-1.15%
NVDA
$224.62
▼-1.71%
SPCX
$153.40
▼-2.01%
SNDK
$1,443.74
▼-2.60%
META
$749.38
▼-1.72%
AAPL
$345.34
▲+1.19%
TSLA
$365.35
▼-2.63%
AMD
$587.31
▼-3.01%
MU
$942.21
▼-1.15%
NVDA
$224.62
▼-1.71%
SPCX
$153.40
▼-2.01%
SNDK
$1,443.74
▼-2.60%
META
$749.38
▼-1.72%
AAPL
$345.34
▲+1.19%
TSLA
$365.35
▼-2.63%
AMD
$587.31
▼-3.01%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Methamphetamine Use Disorder
Recent news which mentions Methamphetamine Use Disorder
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
Tags
Psychedelic/Assisted Therapies
Psilocybin program
Psychedelics
From
Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers
RVVTF
Tags
Markets
Market News
Methamphetamine Use Disorder
From
Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
Tickers
FLHLF
IXHL
SILO
Tags
Global
Generalized Anxiety Disorder
Penny Stocks
From
Benzinga